IL-33/ST2 axis promotes mast cell survival via BCLXL
2014
Mast cells (MC) are long-lived cells that accumulate in inflamed tissues. IL-33 has been characterized extensively as a MC activator, but a contribution of IL-33 and its receptor IL-1 receptor-related protein ST2 to MC survival remains unappreciated. Here, we show that IL-33 attenuates apoptosis of human and murine MC, principally via the antiapoptotic molecule B-cell lymphoma-X large (BCLXL). In vivo, IL-33 and ST2 can confer a cell-intrinsic survival advantage to murine MC, particularly in the context of inflammation. These results identify the IL-33/ST2 axis as an important pathway supporting MC persistence in tissues, raising the possibility that therapeutic targeting of IL-33 could limit the contribution of MC to chronic inflammatory diseases.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
66
References
50
Citations
NaN
KQI